NewLink Genetics: Ready To Test Ebola Vaccine

August 17, 2014 7:49 AM

3 0

NewLink Genetics is planning an initial phase of testing involving up to 100 health volunteers and is talking with regulators about the study, said Brian Wiley, the company's vice president for business development. He declined to say whether the drug developer has submitted an application for the research to the Food and Drug Administration.

Chief Financial Officer Gordon Link said Thursday the timing of the testing, which would involve up to 100 healthy volunteers, is uncertain.

Also read: Gene study clears 'Patient Zero' as cause of U.S. HIV epidemic

Read more

To category page